Eton Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.04-$18.40 |
Market Cap | $380.5M |
Shares Short | 343,924 |
Financials
See moreRevenue (12 Mos) | $39M |
Revenue Growth (YoY) | 59.3% |
Gross Profit (12 Mos) | $23.4M |
Diluted EPS | -$0.15 |
News
See moreYahoo Finance • 16 days ago
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
Yahoo Finance • 30 days ago
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
Yahoo Finance • last month
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
About
CEO | Mr. Sean E. Brynjelsen |
CFO | Mr. James R. Gruber CPA |
Address | 21925 W. Field Parkway, Deer Park, IL, United States, 60010-7278 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 31 |
